Serum testosterone and cardiometabolic risk in Nigerian men with type 2 diabetes: a cross−sectional study
Ezekiel Musa, Esteban Salazar-Petres, Glory Chinuru Musa, Fatima Bello, Adamu Girei Bakari · 2026
Read Serum testosterone and cardiometabolic risk in Nigerian men with type 2 diabetes: a cross−sectional study by Ezekiel Musa, Esteban Salazar-Petres, Glory Chinuru Musa, Fatima Bello, Adamu Girei Bakari (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13314498.txt.
Description
Ezekiel Musa and co-workers probe testosterone and heart-metabolic risk in Nigerian men with diabetes in a study from 2026. Type 2 diabetes weighs heavily on such risk in Nigeria, and low testosterone may worsen artery disease, yet local data were scarce.
The study enrolled 537 adult men: 358 with type 2 diabetes and 179 without, as counted in the report. Men were grouped by diabetes and testosterone level, and the team measured body traits, blood fats, and the hormone itself. Ten-year artery risk was scored with standard American equations. Men with diabetes scored far higher on that risk than controls even before other factors, as the authors report. The work frames testosterone checks as part of heart risk care for diabetic men in Nigeria.
Catalog record
| CREATOR | Ezekiel Musa, Esteban Salazar-Petres, Glory Chinuru Musa, Fatima Bello, Adamu Girei Bakari |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34541 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |